知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

98 条记录 (耗时 0.028 秒)

    AUTOMATED FARMING SYSTEM FOR A ROW CROP INSTALLATION
    82.
    发明申请
    AUTOMATED FARMING SYSTEM FOR A ROW CROP INSTALLATION 有权

    公开(公告)号：US20230116307A1

    公开(公告)日：2023-04-13

    申请号：US17905661

    申请日：2021-03-09

    申请人： ALMA MATER STUDIORUM - UNIVERSITA? DI BOLOGNA

    发明人： Claudio ROSSI ,  Luca CORELLI GRAPPADELLI

    IPC分类号： B61L27/04 ,  B61B5/02 ,  B61C3/02 ,  B61C13/00 ,  B61D15/00 ,  B61L27/30 ,  B61L27/70 ,  B61L25/02 ,  B61L23/04 ,  B60L53/30

    摘要： A farming system (1) for row crop installations (10) comprises: a first plurality of plants (10A) and a second plurality of fruit or vegetable plants (10B), disposed along a first longitudinal axis (L1) and a second longitudinal axis (L2), respectively, and mutually spaced along a transverse direction (T) to form a first row (F1) and a second row (F2); a supporting structure (11), configured to support the plants and including, for the first row (F1) and the second row (F2), a first plurality of posts (11A) and a second plurality of posts (11B); a first rail (12A), connected to the first plurality of posts (11A); a second rail (12B), connected to the second plurality of posts (11B). The first rail (12A) and the second rail (12B) are oriented longitudinally and spaced transversely from each other to define a track (12). The system comprises a trolley (13), movable along the track (12) and including a movement actuator (131), configured to move the trolley (13) on the track (12).

    CATALYST COMPRISING COKE AND PROCESS FOR THE PRODUCTION OF DIENES
    83.
    发明申请
    CATALYST COMPRISING COKE AND PROCESS FOR THE PRODUCTION OF DIENES 有权

    公开(公告)号：US20220339610A1

    公开(公告)日：2022-10-27

    申请号：US17639136

    申请日：2020-08-25

    申请人： VERSALIS S.P.A. ,  ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA

    发明人： Juliana VELASQUEZ OCHOA ,  Fabrizio CAVANI ,  Irene TOSI ,  Erika FARCI ,  Nicola VECCHINI

    IPC分类号： B01J27/20 ,  C07C1/24 ,  B01J21/12 ,  B01J37/08

    摘要： A catalyst having coke wherein the coke, upon analysis by infrared spectroscopy in diffuse reflection, has at least two peaks at a wavelength between 1450 cm−1 and 1700 cm−1.
    The aforesaid catalyst having coke can be advantageously used in a process for the production of a diene, preferably a conjugated diene, more preferably 1,3-butadiene, said process having the dehydration of at least one alkenol having a number of carbon atoms greater than or equal to 4.
    Preferably, the alkenol having a number of carbon atoms greater than or equal to 4 can be obtained directly from biosynthetic processes, or through catalytic dehydration processes of at least one diol.
    When the alkenol is a butenol, the diol is preferably a butanediol, more preferably 1,3-butanediol, even more preferably bio-1,3-butanediol, i.e. 1,3-butanediol deriving from biosynthetic processes.
    When the diol is 1,3-butanediol, or bio-1,3-butanediol, the diene obtained with the process is, respectively, 1,3-butadiene, or bio-1,3-butadiene.

    Herpesvirus with Modified Glycoprotein H for Propagation in a Cell
    87.
    发明申请
    Herpesvirus with Modified Glycoprotein H for Propagation in a Cell 审中-公开

    公开(公告)号：US20190300862A1

    公开(公告)日：2019-10-03

    申请号：US16307708

    申请日：2017-06-08

    申请人： ALMA MATER STUDIORUM UNIVERSITA DI BOLOGNA ,  NOUSCOM AG

    发明人： ALFREDO NICOSIA ,  MARIA GABRIELLA CAMPADELLI

    IPC分类号： C12N7/00 ,  C07K14/005 ,  A61K35/763

    摘要： The present invention is directed to a recombinant herpesvirus which comprises the GCN4 yeast transcription factor or a part thereof fused to or inserted into glycoprotein H and is capable of binding to a target molecule present on a cell for propagation and production of the herpesvirus. The herpesvirus may comprise additional modification in glycoprotein D and/or glycoprotein B for retargeting the herpesvirus to a diseased cell. The present invention is further directed to a nucleic acid and a vector coding for the gH, a polypeptide comprising the gH, and a cell comprising the herpesvirus, nucleic acid, vector or polypeptide. Moreover, the present invention is directed to a cell having accessible on the surface a target molecule for the GCN4 yeast transcription factor or part thereof and to a method for producing the herpesvirus in said cell.

    Augmented reality glasses for medical applications and corresponding augmented reality system
    90.
    发明授权
    Augmented reality glasses for medical applications and corresponding augmented reality system 有权

    公开(公告)号：US10197803B2

    公开(公告)日：2019-02-05

    申请号：US15129750

    申请日：2015-03-27

    申请人： ALMA MATER STUDIORUM—UNIVERSITA' DI BOLOGNA ,  GLASSUP S.R.L.

    发明人： Giovanni Badiali ,  Giovanni Tregnaghi

    IPC分类号： G02B27/01 ,  A61B5/00 ,  G03B21/20 ,  A61B90/00 ,  A61B90/50 ,  G02B27/14 ,  G06F3/0354 ,  G06F3/16

    摘要： The invention describes augmented reality glasses (1) for medical applications configured to be worn by a user, comprising a frame (15) that supports a glasses lens (2a, 2b), wherein the frame (15) comprises an RGB lighting system comprising RGB-emitting devices (16a, 16b, 16c) configured to emit light beams (B1, B2, B3); first optical systems (17a, 17b, 17c) configured to collimate at least partially said beams (B1, B2, B3) into collimated beams (B1c; B2c; B3c); wherein the frame (15) further comprises a display (3) configured to be illuminated by the RGB lighting system (16) by means of the collimated beams (B1c; B2c; B3c); to receive first images (I) from a first processing unit (10); to emit the first images (I) as second images (IE1) towards the glasses lens (2a, 2b), wherein the lens (2a, 2b) is configured to reflect the second images (IE1) coming from the display (3) as images projected (IP) towards an internal zone (51) of the glasses corresponding to an eye position zone of the user who is wearing the glasses in a configuration for use of the glasses. The invention moreover describes an augmented reality system for medical applications on a user comprising the augmented reality glasses (1) of the invention, biomedical instrumentation (100) configured to detect biomedical and/or therapeutic and/or diagnostic data of a user and to generate first data (D1) representative of operational parameters (OP_S) associated with the user, transmitting means (101) configured to transmit the first data (D1) to the glasses (1); wherein the glasses (1) comprise a first processing unit (10) equipped with a receiving module (102) configured to receive the first data (D1) comprising the operational parameters (OP_S) associated with the user.